NO20082365L - Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on - Google Patents

Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on

Info

Publication number
NO20082365L
NO20082365L NO20082365A NO20082365A NO20082365L NO 20082365 L NO20082365 L NO 20082365L NO 20082365 A NO20082365 A NO 20082365A NO 20082365 A NO20082365 A NO 20082365A NO 20082365 L NO20082365 L NO 20082365L
Authority
NO
Norway
Prior art keywords
preparation
thiazolo
pyrimidin
amino
new method
Prior art date
Application number
NO20082365A
Other languages
English (en)
Inventor
Stephen E Webber
Tingmin Wang
John S Ng
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of NO20082365L publication Critical patent/NO20082365L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse angår en fremgangsmåte for fremstilling av tittelforbindelsen, 5-amino-3H-tiazolo[4,5-d]pyrimidin-2-on, som er et anvendelig mellomprodukt ved fremstilling av visse tiazolo[4,5-d]pyrimidin-nukleosider, som kan ha nytte som immunmodulerende midler.
NO20082365A 2005-11-21 2008-05-26 Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on NO20082365L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73805505P 2005-11-21 2005-11-21
PCT/US2006/061111 WO2007062355A2 (en) 2005-11-21 2006-11-20 PROCESS FOR THE PREPARATION OF 5-AMINO-3H- THIAZOLO [4 , 5 -d] PYRIMIDIN- 2 -ONE

Publications (1)

Publication Number Publication Date
NO20082365L true NO20082365L (no) 2008-08-18

Family

ID=37908057

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082365A NO20082365L (no) 2005-11-21 2008-05-26 Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on

Country Status (18)

Country Link
US (1) US7781581B2 (no)
EP (1) EP1973920B1 (no)
JP (1) JP5117391B2 (no)
KR (1) KR20080090400A (no)
CN (1) CN101365705A (no)
AR (1) AR058210A1 (no)
AT (1) ATE474842T1 (no)
AU (1) AU2006318260B2 (no)
BR (1) BRPI0618789A2 (no)
CA (1) CA2630463C (no)
DE (1) DE602006015700D1 (no)
EA (1) EA200801404A1 (no)
ES (1) ES2345904T3 (no)
IL (1) IL191568A0 (no)
NO (1) NO20082365L (no)
SG (1) SG152296A1 (no)
TW (1) TWI383987B (no)
WO (1) WO2007062355A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI418561B (zh) 2006-06-22 2013-12-11 Anadys Pharmaceuticals Inc ５-胺基-３-（３’-去氧-β-Ｄ-核糖呋喃糖基（ｒｉｂｏｆｕｒａｎｏｓｙｌ））-噻唑并〔４，５-ｄ〕嘧啶-２，７-二酮之前藥
WO2012102366A1 (ja) * 2011-01-28 2012-08-02 日本たばこ産業株式会社 新規ピペラジン化合物の製造方法
CN103012284A (zh) * 2012-12-26 2013-04-03 无锡捷化医药科技有限公司 一种2-氨基-5-溴嘧啶类化合物的制备方法
RS61612B1 (sr) 2014-12-08 2021-04-29 Hoffmann La Roche 3-supstituisana 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-dion jedinjenja za lečenje i profilaksu virusne infekcije
AU2018205994B2 (en) 2017-01-06 2021-09-09 F. Hoffmann-La Roche Ag Process for the preparation of 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
CN111635368B (zh) * 2020-06-12 2021-06-29 东莞市东阳光仿制药研发有限公司 一种胺化合物的制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539205A (en) 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4746651A (en) 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5166141A (en) 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
US5011828A (en) 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
GB8712745D0 (en) 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
US4880784A (en) 1987-12-21 1989-11-14 Brigham Young University Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US5041426A (en) 1987-12-21 1991-08-20 Brigham Young University Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
US5041542A (en) 1988-06-03 1991-08-20 Nucleic Acid Research Institute Substituted pyrimido[5,4-d]pyrimidine nucleosides
GB9015914D0 (en) 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
GB9105899D0 (en) 1991-03-20 1991-05-08 Wellcome Found Therapeutic nucleosides
WO1994007904A1 (en) 1992-10-01 1994-04-14 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
US5395937A (en) 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5994321A (en) 1993-12-20 1999-11-30 Aronex Pharmaceuticals, Inc. Antiviral guanine analogs
US5446045A (en) 1993-12-20 1995-08-29 Revankar; Ganapathi R. Antiviral guanine analogs
US5496816A (en) 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
TW552261B (en) 1996-07-03 2003-09-11 Japan Energy Corp Novel purine derivative
DE69729887T2 (de) 1996-10-16 2005-07-28 ICN Pharmaceuticals, Inc., Costa Mesa Purin-L-Nukleoside, Analoga und deren Verwendung
US6509320B1 (en) 1996-10-16 2003-01-21 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
HUP9904665A3 (en) 1996-10-25 2000-11-28 Minnesota Mining And Mfg Co Sa Immune response modifier compounds for treatment of th2 mediated and related diseases
CA2311742C (en) 1997-11-28 2009-06-16 Sumitomo Pharmaceuticals Co., Ltd. 6-amino-9-benzyl-8-hydroxypurine derivatives
TW572758B (en) 1997-12-22 2004-01-21 Sumitomo Pharma Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
CA2326884A1 (en) * 1998-04-03 1999-10-14 Dupont Pharmaceuticals Company Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
US6444652B1 (en) 1998-08-10 2002-09-03 Novirio Pharmaceuticals Limited β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6664260B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Heterocyclic ether substituted imidazoquinolines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
US20020086871A1 (en) 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
JP4331944B2 (ja) 2001-04-17 2009-09-16 大日本住友製薬株式会社 新規アデニン誘導体
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
CN1300165C (zh) 2001-11-27 2007-02-14 安那迪斯药品股份有限公司 3－β－呋喃核糖基噻唑并[4,5－d]嘧啶核苷及其应用
KR20050006221A (ko) 2002-05-06 2005-01-15 제네랩스 테크놀로지스, 인코포레이티드 Ｃ형 간염 바이러스 감염 치료용의 뉴클레오시드 유도체
US7196090B2 (en) * 2002-07-25 2007-03-27 Warner-Lambert Company Kinase inhibitors
WO2005016235A2 (en) 2003-04-14 2005-02-24 The Regents Of The University Of California Combined use of impdh inhibitors with toll-like receptor agonists
EP1632477B1 (en) * 2003-06-12 2017-03-01 Astellas Pharma Inc. Benzamide derivative or salt thereof
ATE465742T1 (de) 2003-09-05 2010-05-15 Anadys Pharmaceuticals Inc Tlr7-liganden zur behandlung von hepatitis c
US20050250820A1 (en) * 2004-03-08 2005-11-10 Amgen Inc. Therapeutic modulation of PPARgamma activity
JP2008516978A (ja) 2004-10-15 2008-05-22 バイエル・フアーマシユーチカルズ・コーポレーシヨン 肥満症の処置のためのビフェニル−４−イル−カルボニルアミノ酸誘導体の製造および使用
JP5303149B2 (ja) * 2004-12-17 2013-10-02 アナディス ファーマシューティカルズ インク ３，５−二置換及び３，５，７−三置換−３Ｈ−オキサゾロ及び３Ｈ−チアゾロ［４，５−ｄ］ピリミジン−２−オン化合物及びそのプロドラッグ
AU2006244074B2 (en) 2005-05-09 2012-12-13 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
TWI418561B (zh) 2006-06-22 2013-12-11 Anadys Pharmaceuticals Inc ５-胺基-３-（３’-去氧-β-Ｄ-核糖呋喃糖基（ｒｉｂｏｆｕｒａｎｏｓｙｌ））-噻唑并〔４，５-ｄ〕嘧啶-２，７-二酮之前藥
JP5225991B2 (ja) 2006-07-18 2013-07-03 アナディス ファーマシューティカルズ インク チアゾロ［４，５−ｄ］ピリミジンのカーボネート及びカルバメートプロドラッグ

Also Published As

Publication number Publication date
ES2345904T3 (es) 2010-10-05
IL191568A0 (en) 2008-12-29
KR20080090400A (ko) 2008-10-08
AR058210A1 (es) 2008-01-23
SG152296A1 (en) 2009-05-29
WO2007062355A2 (en) 2007-05-31
AU2006318260B2 (en) 2012-05-17
CA2630463A1 (en) 2007-05-31
CN101365705A (zh) 2009-02-11
ATE474842T1 (de) 2010-08-15
WO2007062355A3 (en) 2007-07-26
EP1973920B1 (en) 2010-07-21
EA200801404A1 (ru) 2008-10-30
EP1973920A2 (en) 2008-10-01
AU2006318260A1 (en) 2007-05-31
CA2630463C (en) 2015-01-06
US7781581B2 (en) 2010-08-24
BRPI0618789A2 (pt) 2016-08-30
DE602006015700D1 (de) 2010-09-02
TW200736265A (en) 2007-10-01
JP5117391B2 (ja) 2013-01-16
JP2009516709A (ja) 2009-04-23
US20070117979A1 (en) 2007-05-24
TWI383987B (zh) 2013-02-01

Similar Documents

Publication Publication Date Title
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
NO20054404L (no) 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
HRP20181912T1 (hr) Derivati pirolo[2,3-d]pirimidina kao inhibitori janus kinaze
NO345018B1 (no) Framgangsmåte for framstilling av organofluorforbindelser i alkoholholdige løsningsmidler.
NO20081133L (no) Tieno[2,3-B]-pyridin-5-karbonitriler som protein kinase inhibitorer
WO2007023110A3 (en) P38 map kinase inhibitors and methods for using the same
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
EA200801381A1 (ru) Производные пиримидина
CL2007003459A1 (es) Proceso de preparacion de compuestos derivados de pirimidina; y compuesto intermediario (s)-trans-etil 3-etoxi-7-(4-(4-fluorofenil)-6-isopropil-2-(n-metilmetilsulfonamido)pirimidin-5-il)-5-hidroxihep-2,6-dienoato.
WO2009006389A3 (en) Pyrimidine derivatives useful as raf kinase inhibitors
WO2007022459A3 (en) Processes and intermediates
NO20075232L (no) Fremgangsmate for fremstilling av pyrido[2,3-d]pyrimidin-7-on og 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1 H)-on derivater
DK1893587T3 (da) Fremgangsmåde til fremstilling af dihydroquinazoliner
WO2006021378A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2007092095A3 (en) [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases.
WO2005076990A3 (en) Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
WO2006087120A3 (de) Pyrazolopyrimidine
EP1731528A4 (en) PROCESS FOR THE PRODUCTION OF SOLUBILIZED KERATIN
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
EA200802248A1 (ru) Способы применения соединений 4-амино-5-хлортиено[2,3-d]-пиримидина в качестве инсектицидов
IL191568A0 (en) Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2-one
NO20073276L (no) Metode for fremstilling av aminoetoksybenzylalkoholer
WO2007070463A3 (en) Compositions, methods and kits for removing debris from an ocular area

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application